Sáez, María Eugenia
García-Sánchez, Ainhoa
de Rojas, Itziar
Alarcón-Martín, Emilio
Martínez, Joan
Cano, Amanda
García-González, Pablo
Puerta, Raquel
Olivé, Clàudia
Capdevila, Maria
García-Gutiérrez, Fernando
Castilla-Martí, Miguel
Castilla-Martí, Luis
Espinosa, Ana
Alegret, Montserrat
Ricciardi, Mario
Pytel, Vanesa
Valero, Sergi
Tárraga, Lluís
Boada, Mercè
Ruiz, Agustín
Marquié, Marta
Funding for this research was provided by:
ACE alzheimer Center Barcelona (Intramural Funding, Intramural Funding, Intramural Funding, Intramural Funding, Intramural Funding, Intramural Funding, Intramural Funding, Intramural Funding, Intramural Funding, Intramural Funding, Intramural Funding, Intramural Funding, Intramural Funding, Intramural Funding, Intramural Funding, Intramural Funding, Intramural Funding, Intramural Funding, Intramural Funding, Intramural Funding)
Instituto de Salud Carlos III (PI19/00335, PI17/01474, AC17/00100, PI19/01301, PI22/01403, PMP22/00022, PI19/00335, PI17/01474, AC17/00100, PI19/01301, PI22/01403, PMP22/00022, PI19/00335, PI17/01474, AC17/00100, PI19/01301, PI22/01403, PMP22/00022, PI19/00335, PI17/01474, AC17/00100, PI19/01301, PI22/01403, PMP22/00022, PI19/00335, PI17/01474, AC17/00100, PI19/01301, PI22/01403, PMP22/00022, PI19/00335, PI17/01474, AC17/00100, PI19/01301, PI22/01403, PMP22/00022, PI19/00335, PI17/01474, AC17/00100, PI19/01301, PI22/01403, PMP22/00022, PI19/00335, PI17/01474, AC17/00100, PI19/01301, PI22/01403, PMP22/00022, PI19/00335, PI17/01474, AC17/00100, PI19/01301, PI22/01403, PMP22/00022)
Article History
Received: 1 July 2023
Accepted: 26 January 2024
First Online: 16 February 2024
Declarations
:
: This study and its informed consent were approved by the Ethics Committees of the Hospital Clínic i Provincial de Barcelona in accordance with Spanish biomedical laws (Law 14/2007, July 3rd, about biomedical research; Royal Decree 1716/2011, November 18th) and followed the recommendations of the Declaration of Helsinki. The patients/participants provided their written informed consent to participate in this study.
: All authors have read and approved the final manuscript for publication.
: MB has consulted for Araclon, Avid, Grifols, Lilly, Nutricia, Roche, Eisai, and Servier. She has received fees from lectures and funds for research from Araclon, Biogen, Grifols, Nutricia, Roche, and Servier. She reports grants/research funding from Abbvie, Araclon, Biogen Research Limited, Bioiberica, Grifols, Lilly, S.A, Merck Sharp & Dohme, Kyowa Hakko Kirin, Laboratorios Servier, Nutricia SRL, Oryzon Genomics, Piramal Imaging Limited, Roche Pharma SA, and Schwabe Farma Iberica SLU, all outside the submitted work. She has not received personal compensation from these organizations. AR is a member of the scientific advisory board of Landsteiner Genmed and Grifols SA. AR has stocks in Landsteiner Genmed. MM has consulted for F. Hoffmann-La Roche Ltd. The rest of authors declare that they have no competing interests.